Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vimal H Prajapati

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Skin Therapy Letter|January 19, 2023
Tralokinumab for Moderate-to-Severe Atopic Dermatitis in AdultsAbrahim Abduelmula, Brian D Rankin, Asfandyar Mufti, et al.
JAAD Case Reports|November 5, 2019
Successful treatment of multinucleate cell angiohistiocytoma in an adult male patient with potassium-titanyl-phosphate laser in combination with intralesional corticosteroidsBryn Edgerton, Malika A Ladha, Charlene Hunter, et al.
Journal of Cutaneous Medicine and Surgery|March 19, 2026
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment ParadigmsJensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
Journal of the American Academy of Dermatology|January 30, 2024
Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapy: A phase 4, multicenter, open-label studyKim Papp, Vimal H Prajapati, Catherine Maari, et al.
International Journal of Rheumatic Diseases|January 8, 2026
Disease Course and Risk of Relapse in Juvenile Localized Scleroderma: A Single-Center Retrospective StudyMerna Adly, Vimal H Prajapati, Rebeka Stevenson, et al.
Dermatology and Therapy|May 29, 2025
Tildrakizumab Treatment Patterns in Adults With Moderate-to-Severe Plaque Psoriasis: A Retrospective Analysis From the Canadian Patient Support ProgramVimal H Prajapati, Nicole Bellefontaine, Devi Gopalan, et al.
Journal of the American Academy of Dermatology|March 29, 2023
Use of Janus kinase inhibitors for granulomatous dermatoses: A systematic reviewSiddhartha Sood, Martin Heung, Jorge R Georgakopoulos, et al.
JAAD International|October 31, 2022
Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based reviewAbrahim Abduelmula, Asfandyar Mufti, Derrick H Y Chong, et al.
Skin Therapy Letter|May 9, 2022
Halobetasol Propionate 0.01% Lotion for Plaque Psoriasis and Corticosteroid-Responsive DermatosesAbrahim Abduelmula, Brian D Rankin, Ronald Vender, et al.
Journal of Cutaneous Medicine and Surgery|October 3, 2022
Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based ReviewAbrahim Abduelmula, Asfandyar Mufti, Jenna Mistry, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Skin Therapy Letter|January 19, 2023
Tralokinumab for Moderate-to-Severe Atopic Dermatitis in AdultsAbrahim Abduelmula, Brian D Rankin, Asfandyar Mufti, et al.
JAAD Case Reports|November 5, 2019
Successful treatment of multinucleate cell angiohistiocytoma in an adult male patient with potassium-titanyl-phosphate laser in combination with intralesional corticosteroidsBryn Edgerton, Malika A Ladha, Charlene Hunter, et al.
Journal of Cutaneous Medicine and Surgery|March 19, 2026
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment ParadigmsJensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
Journal of the American Academy of Dermatology|January 30, 2024
Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapy: A phase 4, multicenter, open-label studyKim Papp, Vimal H Prajapati, Catherine Maari, et al.
International Journal of Rheumatic Diseases|January 8, 2026
Disease Course and Risk of Relapse in Juvenile Localized Scleroderma: A Single-Center Retrospective StudyMerna Adly, Vimal H Prajapati, Rebeka Stevenson, et al.
Dermatology and Therapy|May 29, 2025
Tildrakizumab Treatment Patterns in Adults With Moderate-to-Severe Plaque Psoriasis: A Retrospective Analysis From the Canadian Patient Support ProgramVimal H Prajapati, Nicole Bellefontaine, Devi Gopalan, et al.
Journal of the American Academy of Dermatology|March 29, 2023
Use of Janus kinase inhibitors for granulomatous dermatoses: A systematic reviewSiddhartha Sood, Martin Heung, Jorge R Georgakopoulos, et al.
JAAD International|October 31, 2022
Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based reviewAbrahim Abduelmula, Asfandyar Mufti, Derrick H Y Chong, et al.
Skin Therapy Letter|May 9, 2022
Halobetasol Propionate 0.01% Lotion for Plaque Psoriasis and Corticosteroid-Responsive DermatosesAbrahim Abduelmula, Brian D Rankin, Ronald Vender, et al.
Journal of Cutaneous Medicine and Surgery|October 3, 2022
Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based ReviewAbrahim Abduelmula, Asfandyar Mufti, Jenna Mistry, et al.
Pageof 11